Current Focus: Incanthera’s Skincare Range

Skin + CELL’s luxury skincare current range extends across face, body, hand, face serum and eye serum, and will also include SPF concentrations and further bioactive derivatives of vitamins in the future.

Independent studies have shown Incanthera’s technology is uniquely effective in delivering Bioactive B3 below the dermal barrier, energising the living cells of the skin to optimise cellular health, energy and protective capabilities.

In December 2023, Incanthera announced a commercial skincare deal for the launch of Skin + CELL with Marionnaud Switzerland and Austria (“Marionnaud”), part of the A.S. Watson Group (“A.S. Watson”).

A.S. Watson is the world’s largest international health, beauty, and lifestyle brand retailer with 16,100 stores serving 5.3 billion customers across 28 markets.

Incanthera’s unique skincare range will be launched under our luxury skincare brand Skin + CELL which will be available exclusively initially in Marionnaud’s stores in Switzerland and Austria from Q2 2024 with the roll out into the remaining 1,100 stores across European markets expected to follow thereafter in 2024.

Further rollouts are being planned across Asia. These are considered ideal markets for our products given the consumer focus on skin-health and beauty and A.S. Watson’s sheer dominance in these retail markets.

The launch of Skin + CELL with Marionnaud is transformational for Incanthera and based on the potential market forecasts of Marionnaud, is expected to generate significant revenues and profitability in 2024 and beyond.